These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 16333246

  • 1. The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia.
    Hubeek I, Stam RW, Peters GJ, Broekhuizen R, Meijerink JP, van Wering ER, Gibson BE, Creutzig U, Zwaan CM, Cloos J, Kuik DJ, Pieters R, Kaspers GJ.
    Br J Cancer; 2005 Dec 12; 93(12):1388-94. PubMed ID: 16333246
    [Abstract] [Full Text] [Related]

  • 2. Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia.
    Stam RW, den Boer ML, Meijerink JP, Ebus ME, Peters GJ, Noordhuis P, Janka-Schaub GE, Armstrong SA, Korsmeyer SJ, Pieters R.
    Blood; 2003 Feb 15; 101(4):1270-6. PubMed ID: 12406912
    [Abstract] [Full Text] [Related]

  • 3. Potential mechanisms of resistance to cytarabine in AML patients.
    Galmarini CM, Thomas X, Calvo F, Rousselot P, El Jafaari A, Cros E, Dumontet C.
    Leuk Res; 2002 Jul 15; 26(7):621-9. PubMed ID: 12008078
    [Abstract] [Full Text] [Related]

  • 4. RNA expression of genes involved in cytarabine metabolism and transport predicts cytarabine response in acute myeloid leukemia.
    Abraham A, Varatharajan S, Karathedath S, Philip C, Lakshmi KM, Jayavelu AK, Mohanan E, Janet NB, Srivastava VM, Shaji RV, Zhang W, Abraham A, Viswabandya A, George B, Chandy M, Srivastava A, Mathews V, Balasubramanian P.
    Pharmacogenomics; 2015 Jul 15; 16(8):877-90. PubMed ID: 26083014
    [Abstract] [Full Text] [Related]

  • 5. In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia.
    Galmarini CM, Thomas X, Calvo F, Rousselot P, Rabilloud M, El Jaffari A, Cros E, Dumontet C.
    Br J Haematol; 2002 Jun 15; 117(4):860-8. PubMed ID: 12060121
    [Abstract] [Full Text] [Related]

  • 6. Intracellular cytarabine triphosphate production correlates to deoxycytidine kinase/cytosolic 5'-nucleotidase II expression ratio in primary acute myeloid leukemia cells.
    Yamauchi T, Negoro E, Kishi S, Takagi K, Yoshida A, Urasaki Y, Iwasaki H, Ueda T.
    Biochem Pharmacol; 2009 Jun 15; 77(12):1780-6. PubMed ID: 19428333
    [Abstract] [Full Text] [Related]

  • 7. [Relationship between the expression of the genes encoding the key enzymes for cytarabine metabolism and the pharmacokinetics of cytarabine in the treatment of childhood acute leukemia with high-dose cytarabine].
    Xie XT, Jiang SY, Li BS, Yang LL.
    Zhonghua Er Ke Za Zhi; 2008 Apr 15; 46(4):276-80. PubMed ID: 19099730
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxic activity of gemcitabine and correlation with expression profile of drug-related genes in human lymphoid cells.
    Giovannetti E, Mey V, Loni L, Nannizzi S, Barsanti G, Savarino G, Ricciardi S, Del Tacca M, Danesi R.
    Pharmacol Res; 2007 Apr 15; 55(4):343-9. PubMed ID: 17296311
    [Abstract] [Full Text] [Related]

  • 9. Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down syndrome and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin.
    Taub JW, Huang X, Matherly LH, Stout ML, Buck SA, Massey GV, Becton DL, Chang MN, Weinstein HJ, Ravindranath Y.
    Blood; 1999 Aug 15; 94(4):1393-400. PubMed ID: 10438727
    [Abstract] [Full Text] [Related]

  • 10. Determinants of sensitivity and resistance to gemcitabine: the roles of human equilibrative nucleoside transporter 1 and deoxycytidine kinase in non-small cell lung cancer.
    Achiwa H, Oguri T, Sato S, Maeda H, Niimi T, Ueda R.
    Cancer Sci; 2004 Sep 15; 95(9):753-7. PubMed ID: 15471562
    [Abstract] [Full Text] [Related]

  • 11. Cytarabine-resistant leukemia cells are moderately sensitive to clofarabine in vitro.
    Yamauchi T, Uzui K, Nishi R, Shigemi H, Ueda T.
    Anticancer Res; 2014 Apr 15; 34(4):1657-62. PubMed ID: 24692694
    [Abstract] [Full Text] [Related]

  • 12. Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine.
    Galmarini CM, Thomas X, Graham K, El Jafaari A, Cros E, Jordheim L, Mackey JR, Dumontet C.
    Br J Haematol; 2003 Jul 15; 122(1):53-60. PubMed ID: 12823345
    [Abstract] [Full Text] [Related]

  • 13. Expression Levels of Human Equilibrative Nucleoside Transporter 1 and Deoxycytidine Kinase Enzyme as Prognostic Factors in Patients with Acute Myeloid Leukemia Treated with Cytarabine.
    Candelaria M, Corrales-Alfaro C, Gutiérrez-Hernández O, Díaz-Chavez J, Labardini-Méndez J, Vidal-Millán S, Herrera LA.
    Chemotherapy; 2016 Jul 15; 61(6):313-8. PubMed ID: 27119162
    [Abstract] [Full Text] [Related]

  • 14. Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer.
    Ferrandina G, Mey V, Nannizzi S, Ricciardi S, Petrillo M, Ferlini C, Danesi R, Scambia G, Del Tacca M.
    Cancer Chemother Pharmacol; 2010 Mar 15; 65(4):679-86. PubMed ID: 19639316
    [Abstract] [Full Text] [Related]

  • 15. In vitro sensitivity and cross-resistance to deoxynucleoside analogs in childhood acute leukemia.
    Hubeek I, Peters GJ, Broekhuizen R, Zwaan CM, Kaaijk P, van Wering ES, Gibson BE, Creutzig U, Janka-Schaub GE, den Boer ML, Pieters R, Kaspers GJ.
    Haematologica; 2006 Jan 15; 91(1):17-23. PubMed ID: 16434366
    [Abstract] [Full Text] [Related]

  • 16. Defective expression of deoxycytidine kinase in cytarabine-resistant acute myeloid leukemia cells.
    Song JH, Kim SH, Kweon SH, Lee TH, Kim HJ, Kim HJ, Kim TS.
    Int J Oncol; 2009 Apr 15; 34(4):1165-71. PubMed ID: 19287976
    [Abstract] [Full Text] [Related]

  • 17. Long term cultured HL-60 cells are intrinsically resistant to Ara-C through high CDA activity.
    Tang J, Xie X, Zhang X, Qiao X, Jiang S, Shi W, Shao Y, Zhou X.
    Front Biosci (Landmark Ed); 2012 Jan 01; 17(2):569-74. PubMed ID: 22201761
    [Abstract] [Full Text] [Related]

  • 18. The prognostic value of cN-II and cN-III enzymes in adult acute myeloid leukemia.
    Galmarini CM, Cros E, Thomas X, Jordheim L, Dumontet C.
    Haematologica; 2005 Dec 01; 90(12):1699-701. PubMed ID: 16330448
    [Abstract] [Full Text] [Related]

  • 19. Expression of the nucleoside transporters hENT1 (SLC29) and hCNT1 (SLC28) in pediatric acute myeloid leukemia.
    Jaramillo AC, Hubeek I, Broekhuizen R, Pastor-Anglada M, Kaspers GJL, Jansen G, Cloos J, Peters GJ.
    Nucleosides Nucleotides Nucleic Acids; 2020 Dec 01; 39(10-12):1379-1388. PubMed ID: 32312148
    [Abstract] [Full Text] [Related]

  • 20. Effect of dexamethasone on the antileukemic effect of cytarabine: role of deoxycytidine kinase.
    Jaramillo AC, Bergman AM, Comijn EM, Jansen G, Kaspers GJL, Cloos J, Peters GJ.
    Nucleosides Nucleotides Nucleic Acids; 2020 Dec 01; 39(10-12):1346. PubMed ID: 32727269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.